Alex Dmitrienko

Alex Dmitrienko
Founder and President of Mediana Inc.

Alex Dmitrienko, PhD, is Founder and President of Mediana Inc. He is actively involved in biostatistical research with an emphasis on multiplicity issues in clinical trials, subgroup analysis, innovative trial designs, and clinical trial optimization. Dr. Dmitrienko coauthored the first edition of Analysis of Clinical Trials Using SAS®: A Practical Guide, and he coedited Pharmaceutical Statistics Using SAS®: A Practical Guide.           

By This Author

Analysis of Clinical Trials Using SAS: A Practical Guide, Second Edition: An Introduction to Lifetime Probabilities

Analysis of Clinical Trials Using SAS®: A Practical Guide, Second Edition

Edited by Alex Dmitrienko and Gary G. Koch

Analyze your clinical trial data with ease. This book bridges the gap between modern statistical methodology and real-world clinical trial applications. Step-by-step instructions illustrated with examples from actual trials and case studies serve to define a statistical method and its relevance in a clinical trials setting and to illustrate how to implement the method rapidly and efficiently using the power of SAS software.

Pharmaceutical Statistics Using SAS®: A Practical Guide

Pharmaceutical Statistics Using SAS®: A Practical Guide

Edited by Alex Dmitrienko, Christy Chuang-Stein, and Ralph B. D'Agostino

Introduces a range of data analysis problems encountered in drug development and illustrates them using case studies from actual pre-clinical experiments and clinical studies. Includes a discussion of methodological issues, practical advice from subject matter experts, and review of relevant regulatory guidelines. 

Analysis of clinical trials using SAS

Analysis of Clinical Trials Using SAS®: A Practical Guide

By Alex Dmitrienko, Geert Molenberghs, Christy Chuang-Stein, and Walter Offen

This comprehensive guide bridges the gap between statistical methodology and real-world clinical trial applications. Topics reflect the International Conference on Harmonization (ICH) guidelines for the pharmaceutical industry and address important statistical problems encountered in clinical trials. 

Back to Top